| NCT Number | NCT06530667 |
| Lead Sponsor | Shanghai Zhongshan Hospital |
| Conditions | Lung Neoplasm Malignant, Secondary Lung Cancer |
| Enrollment | 3 participants |
| Start Date | 2024-07-31 |
| Primary Completion | 2025-04-30 (estimated) |
| Study Completion | 2025-07-31 (estimated) |
| Updated on ClinicalTrials.gov | 2024-07-31 |